Observations on after-effect duration of kidney-nourishing and marrow-replenishing therapy on 58 cases of Mediterranean anemia
- PMID: 20112483
- DOI: 10.1016/s0254-6272(09)60077-7
Observations on after-effect duration of kidney-nourishing and marrow-replenishing therapy on 58 cases of Mediterranean anemia
Abstract
Objective: To observe the after-effect duration of kidney-nourishing and marrow-replenishing therapy on Mediterranean anemia.
Methods: To observe the kidney-nourishing and marrow-replenishing therapy on 58 cases of Mediterranean anemia and the influence of various relative factors on the after-effect duration.
Results: The after-effect duration on 58 cases varied from 3-6 months, about 4 months on average, and was not influenced by sex, clinical types, genetic types, types of Mediterranean anemia and other factors.
Conclusion: Kidney-nourishing and marrow-replenishing therapy used to treat Mediterranean anemia can not only produce good therapeutic effect during treatment but also keep after effect lasting for about 4 months, indicating that the therapy used to treat Mediterranean anemia has good clinical after effect.
Similar articles
-
[Clinical observation on treatment of 43 women with polycystic ovary syndrome based on syndrome differentiation].Zhong Xi Yi Jie He Xue Bao. 2006 Nov;4(6):585-8. doi: 10.3736/jcim20060608. Zhong Xi Yi Jie He Xue Bao. 2006. PMID: 17090372 Chinese.
-
[Effects of yisui shengxue granules on expressions of alpha-hemoglobin stabilizing protein and erythroid transcription factor GATA-1 mRNAs in bone marrow of patients with beta-thalassemia].Zhong Xi Yi Jie He Xue Bao. 2006 May;4(3):247-50. doi: 10.3736/jcim20060305. Zhong Xi Yi Jie He Xue Bao. 2006. PMID: 16696909 Chinese.
-
Antithymocyte globulin/antilymphocyte globulin plus kidney-nourishing Chinese medicinal: effect on severe aplastic anemia.J Tradit Chin Med. 2012 Dec;32(4):604-8. doi: 10.1016/s0254-6272(13)60078-3. J Tradit Chin Med. 2012. PMID: 23427396 Clinical Trial.
-
[Application of kidney-nourishing herbal medicine for treating hypertension].Zhongguo Zhong Yao Za Zhi. 2013 Dec;38(23):4015-9. Zhongguo Zhong Yao Za Zhi. 2013. PMID: 24791479 Review. Chinese.
-
[Mediterranean anemia and the cardiovascular system].Cardiologia. 1997 Mar;42(3):245-55. Cardiologia. 1997. PMID: 9172931 Review. Italian. No abstract available.
Cited by
-
Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias.Cochrane Database Syst Rev. 2023 Jan 13;1(1):CD013767. doi: 10.1002/14651858.CD013767.pub2. Cochrane Database Syst Rev. 2023. PMID: 36637054 Free PMC article.
-
Genomewide DNA Methylation Responses in Patients with β-Thalassemia Treated with Yisui Shengxue Granules ().Chin J Integr Med. 2019 Jul;25(7):490-496. doi: 10.1007/s11655-018-2777-9. Epub 2018 May 3. Chin J Integr Med. 2019. PMID: 29761313 Clinical Trial.
-
Clinical Effect and Mechanism of Yisui Shengxue Granules in Thalassemia Patients with Mild, Moderate, or Severe Anemia.Evid Based Complement Alternat Med. 2016;2016:1713897. doi: 10.1155/2016/1713897. Epub 2016 Feb 2. Evid Based Complement Alternat Med. 2016. PMID: 26949404 Free PMC article.